Skip to main content

Emerging Technologies

By Adam Ang | 11:39 pm | February 26, 2026
It has demonstrated high accuracy in detecting pancreatic cancer by extracting and analysing 260,000 metabolic signals from just 500 microlitres of blood serum.
By Adam Ang | 06:10 pm | February 24, 2026
Funded by the Queensland government, a University of Queensland project is developing a VR program for practising safe falls for the first time among patients with spinal cord injury.
By Adam Ang | 07:33 am | February 24, 2026
A neurologist's startup has developed a foundation model, based on 60,000 hours of brain wave records, which reportedly achieved 95% accuracy in identifying epilepsy biomarkers.
By HIMSS TV | 09:45 am | February 23, 2026
Shlomi Madar, CEO of SpotitEarly, discusses the company's noninvasive test using a breath sample, which is analyzed by specially trained dogs capable of identifying unique cancer-related scent signatures combined with AI technology.
By Jessica Hagen | 12:54 pm | February 20, 2026
The University of Kansas Health System, KU Medical Center, Children's Mercy and BAMF Health are partnering to develop a theranostics platform for adult and pediatric patients.
By Adam Ang | 06:04 pm | February 19, 2026
Extensive clinical validation and deployment are what remain to make it routine, according to University of New South Wales Scientia Professor Justin Gooding.
Emerging Technologies
By Jessica Hagen | 11:29 am | February 17, 2026
Esther Kim, head of emerging technologies and solutions at Mass General Brigham, speaks with MobiHealthNews about evaluating new technologies through an operational lens and balancing innovation with real-world feasibility.
Emerging Technologies
By HIMSS TV | 09:17 am | February 17, 2026
Esther Kim, head of emerging technologies at Mass General Brigham, shares how the health system evaluates new technologies and decides which innovations to explore while considering clinical need, operational feasibility and scalability.
Emerging Technologies
By Jessica Hagen | 01:40 pm | February 12, 2026
Dr. Amit Zabtani, cofounder and CMO of CustoMED and orthopedic surgeon at UCLA, joins MobiHealthNews to discuss 3D printing personalized surgical instruments.
Emerging Technologies
By HIMSS TV | 09:47 am | February 12, 2026
Dr. Amit Zabtani, an orthopedic surgeon at UCLA and cofounder and CMO of CustoMED, says the company uses 3D printing to create patient-specific instruments based on an individual’s anatomy, enabling more precise positioning during surgery.